C Puoti

Summary

Affiliation: Marino Hospital
Country: Italy

Publications

  1. pmc HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
    Adriano M Pellicelli
    Liver Unit Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense, 87 00149, Rome, Italy
    BMC Gastroenterol 12:162. 2012
  2. doi request reprint How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino General Hospital, Rome, Italy
    Eur J Intern Med 24:100-3. 2013
  3. doi request reprint Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma
    C Puoti
    Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    J Viral Hepat 19:229-35. 2012
  4. ncbi request reprint Hepatitis C virus with normal transaminase levels
    Claudio Puoti
    Department of Internal Medicine, Marino Hospital, Rome, Italy
    Dig Dis 25:277-8. 2007
  5. ncbi request reprint Antiviral treatment of HCV carriers with persistently normal ALT levels
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino Hospital, Viale XXIV Maggio, 00047 Marino, Roma, Italy
    Mini Rev Med Chem 8:150-2. 2008
  6. doi request reprint Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study
    Claudio Puoti
    Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    Liver Int 29:1479-84. 2009
  7. ncbi request reprint Surveillance of patients with chronic hepatitis C not on antiviral therapy: a practical approach
    Claudio Puoti
    Department of Internal Medicine and Digestive Diseases, Marino Hospital, Viale XXIV Maggio, 00047 Marino, Rome, Italy
    Rom J Gastroenterol 14:141-6. 2005
  8. doi request reprint Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases
    Claudio Puoti
    Department of Internal Medicine and Liver Unit, Marino General Hospital, Rome, Italy
    J Gastroenterol Hepatol 24:1847-51. 2009
  9. ncbi request reprint HCV carriers with persistently normal ALT Levels: not too much healthy, not true patients
    Claudio Puoti
    Dept of Gastroenterology and Internal Medicine, Genzano Hospital, Genzano, Via Achille Grandi 43, 00045 Rome, Italy
    Rom J Gastroenterol 13:329-32. 2004
  10. doi request reprint HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    Eur J Intern Med 21:57-61. 2010

Collaborators

Detail Information

Publications31

  1. pmc HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
    Adriano M Pellicelli
    Liver Unit Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense, 87 00149, Rome, Italy
    BMC Gastroenterol 12:162. 2012
    ..The aim of this study is to determine whether the HCV genotype 1 subtypes 1a and 1b respond differently to treatment with PEGylated interferon (PEG-IFN) plus ribavirin...
  2. doi request reprint How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino General Hospital, Rome, Italy
    Eur J Intern Med 24:100-3. 2013
    ....
  3. doi request reprint Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma
    C Puoti
    Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    J Viral Hepat 19:229-35. 2012
    ..This review is aimed at approaching the main unresolved issues on this topic, trying to give evidence-based answers to the more frequently asked questions from patients and their physicians...
  4. ncbi request reprint Hepatitis C virus with normal transaminase levels
    Claudio Puoti
    Department of Internal Medicine, Marino Hospital, Rome, Italy
    Dig Dis 25:277-8. 2007
    ....
  5. ncbi request reprint Antiviral treatment of HCV carriers with persistently normal ALT levels
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino Hospital, Viale XXIV Maggio, 00047 Marino, Roma, Italy
    Mini Rev Med Chem 8:150-2. 2008
    ..There are numerous other factors which impact on this decision, including genotype, histology, patients motivation, symptoms, co-morbid illness, and the age of the patient...
  6. doi request reprint Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study
    Claudio Puoti
    Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    Liver Int 29:1479-84. 2009
    ..To evaluate, in clinical practice, the efficacy and safety of combined antiviral treatment in hepatitis C virus (HCV) carriers with normal alanine aminotransferase (ALT) levels...
  7. ncbi request reprint Surveillance of patients with chronic hepatitis C not on antiviral therapy: a practical approach
    Claudio Puoti
    Department of Internal Medicine and Digestive Diseases, Marino Hospital, Viale XXIV Maggio, 00047 Marino, Rome, Italy
    Rom J Gastroenterol 14:141-6. 2005
    ..This surveillance strategy relies upon the judicious use of un-expensive and widely available tests...
  8. doi request reprint Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases
    Claudio Puoti
    Department of Internal Medicine and Liver Unit, Marino General Hospital, Rome, Italy
    J Gastroenterol Hepatol 24:1847-51. 2009
    ....
  9. ncbi request reprint HCV carriers with persistently normal ALT Levels: not too much healthy, not true patients
    Claudio Puoti
    Dept of Gastroenterology and Internal Medicine, Genzano Hospital, Genzano, Via Achille Grandi 43, 00045 Rome, Italy
    Rom J Gastroenterol 13:329-32. 2004
    ..Sudden worsening of disease with ALT increase and histological deterioration has been described after up to 15 years of follow-up...
  10. doi request reprint HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem
    Claudio Puoti
    Dept of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    Eur J Intern Med 21:57-61. 2010
    ....
  11. doi request reprint Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study
    C Puoti
    Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy
    J Viral Hepat 18:393-9. 2011
    ..Persistently normal alanine aminotransferase levels patients with genotype 2 or 3 have a high chance of achieving SVR, so retesting of HCV RNA during treatment may have no additional practical value in these subjects...
  12. ncbi request reprint Clinical management of HCV carriers with normal aminotransferase levels
    C Puoti
    Department of Gastroenterology and Internal Medicine, E De Santis Hospital, Via A Grandi 43, 00045 Genzano, Rome, Italy
    Dig Liver Dis 35:362-9. 2003
    ..Liver biopsy can be reasonably proposed only in selected cases. Until the results of studies with PEG interferon plus ribavirin are available, HCV carriers should not receive antiviral treatment outside controlled experimental studies...
  13. ncbi request reprint Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease
    C Puoti
    Dept of Gastroenterology and Internal Medicine, Genzano Hospital, Rome, Italy
    Dig Liver Dis 34:802-7. 2002
    ..Very few data exist concerning the level of hepatitis C virus replication within the cirrhotic liver and its relationship to disease severity and progression...
  14. ncbi request reprint Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)
    Claudio Puoti
    Department of Gastroenterology and Internal Medicine, Genzano Hospital, Via Cimone 171, 00141 Rome, Italy
    J Hepatol 37:117-23. 2002
    ..To evaluate demographic characteristics, liver histology and virological features of hepatitis C virus (HCV) carriers with normal alanine transaminase (ALT) levels...
  15. ncbi request reprint Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?
    C Puoti
    Dept of Internal Medicine and Hepato Gastroenterology, Genzano General Hospital, Rome, Italy
    Dig Liver Dis 32:634-43. 2000
    ..Thus, interferon or combination antiviral treatment of hepatitis C virus carriers with normal aminotransferase values should be avoided in clinical practice...
  16. doi request reprint Peripheral blood serum markers for apoptosis and liver fibrosis: are they trustworthy indicators of liver realness?
    F Torre
    Department of Internal Medicine, University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy
    Dig Liver Dis 40:441-5. 2008
    ....
  17. ncbi request reprint First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis
    G Vennarecci
    Division of Surgical Oncology and Liver Transplantation, Regina Elena Cancer Institute, Rome, Italy
    Transplant Proc 39:1857-60. 2007
    ..The present study focused on nine patients with hepatocellular carcinoma (HCC) associated with Child A liver cirrhosis undergoing first-line liver resection and salvage liver transplantation (SLT) for liver tumor recurrence...
  18. ncbi request reprint Steatosis and portal hypertension
    C Puoti
    Department of Gastroenterology and Internal Medicine, Ospedale di Genzano, Rome, Italy
    Eur Rev Med Pharmacol Sci 9:285-90. 2005
    ..In contrast, other studies found a correlation between the severity of steatosis and clinical or lab parameters of PH. We can conclude that up to now it is not actually clear whether steatosis in itself might affect portal pressure...
  19. ncbi request reprint Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis
    Lia Bellis
    Haemodynamic Unit, Marino General Hospital, Via XXIV Maggio, 00047 Marino, Rome, Italy
    J Gastrointestin Liver Dis 16:273-7. 2007
    ..To evaluate whether the hepatic venous pressure gradient (HVPG) differs between cirrhotic patients with severe portal hypertensive gastropathy (PHG) and those with mild or absent PHG...
  20. ncbi request reprint Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis
    Lia Bellis
    Department of Gastroenterology and Internal Medicine, Genzano Hospital E De Santis, Rome, Italy
    Eur J Gastroenterol Hepatol 15:1085-9. 2003
    ..This study was aimed at comparing the severity of portal hypertension in patients with HCV-related or alcoholic cirrhosis...
  21. doi request reprint Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation
    Adriano M Pellicelli
    Liver Unit, Azienda Ospedaliera San Camillo, Forlanini, Rome, Italy
    Angiology 61:802-6. 2010
    ..Endothelin 1 and IL-6 could be implicated in the pathogenesis of PPHTN. On the basis of these results, ET-1 receptor antagonists or anti-IL-6 could have a rationale in the treatment of PPHTN...
  22. ncbi request reprint Extrahepatic manifestations of chronic HCV infection
    Alessandra Galossi
    Department of Internal Medicine, Marino General Hospital, Via XXIV Maggio, 00045 Marino, Rome, Italy
    J Gastrointestin Liver Dis 16:65-73. 2007
    ..The clinical pattern of joint involvement in the course of HCV infection varies from a rheumatoid arthritis-like form (very rare), to a non erosive oligoarthritis involving the large-sized and middle joints...
  23. ncbi request reprint HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy
    Claudio Puoti
    J Hepatol 38:529-32. 2003
  24. ncbi request reprint HCV carriers with persistently normal aminotransferase levels
    Claudio Puoti
    Hepatology 40:266-7; author reply 267-8. 2004
  25. ncbi request reprint Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels
    Claudio Puoti
    Hepatology 41:683; author reply 684. 2005
  26. ncbi request reprint Chronic hepatitis C and 'normal' ALT levels: treat the disease not the test
    Claudio Puoti
    J Hepatol 43:534-5. 2005
  27. ncbi request reprint Occurrence of hepatocellular carcinoma in an apparently 'healthy' HCV patient
    Claudio Puoti
    Eur J Gastroenterol Hepatol 17:1263-4. 2005
  28. ncbi request reprint Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin
    Eric Snoeck
    Exprimo NV, Mechelen, Belgium
    Liver Int 28:61-71. 2008
    ..Currently, the approved dosage of ribavirin has not been studied in patients with 'normal' alanine aminotransferase (ALT) levels...
  29. ncbi request reprint Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma
    Guido Rasi
    National Research Council, Istituto di Neurobiologia e Medicina Molecolare, Via Fosso del Cavaliere 100, 00133 Rome, Italy
    World J Gastroenterol 13:4986-95. 2007
    ..To define NGF (nerve growth factor) and its high-affinity receptor trkA(NGF) presence and distribution in fibrotic liver and in HCC, and to verify if NGF might have a role in fibrosis and HCC...
  30. ncbi request reprint Antiviral treatment of HCV-related chronic hepatitis: is the cup half empty, or half full?
    Claudio Puoti
    J Gastrointestin Liver Dis 16:171-2. 2007
  31. ncbi request reprint Prediction of histology in hepatitis C
    Claudio Puoti
    Hepatology 37:950-1; author reply 951. 2003